| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07383441 Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer |
Recruitment opened |
| 2026-06-12 | NCT07383441 Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer |
Trial sites expanded: 0 -> 41 locations |
| 2026-06-09 | NCT03939481 Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in… |
Primary endpoint(s) modified |
| 2026-06-04 | NCT05642572 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has… |
date change Primary completion pushed: 2026-05-31 -> 2027-06-30 |
| 2026-06-04 | NCT05642572 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has… |
date change Completion pushed: 2027-05-31 -> 2028-06-30 |
| 2026-05-19 | NCT02438722 S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly… |
Trial completed |
| 2026-05-19 | NCT02438722 S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly… |
date change Completion moved earlier: 2026-12-31 -> 2026-04-17 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07638722 Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating… | Phase 2 | Not Yet Recruiting |
| 2026-06-09 | NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… | Phase 2 | Not Yet Recruiting |
| 2026-05-29 | NCT07615049 Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07498205 | Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low… | Myelofibrosis | Not Yet Recruiting |
| Phase 3 | |||
| NCT06470243 | Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will… | Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT06807437 | Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a… | Pancreatic Carcinoma | Recruiting |
| NCT07018869 | Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC)… | Colorectal Cancer Stage II | Recruiting |
| NCT05642611 | Comparing Cooling and/or Compression Approaches of Limbs for Prevention of… | Malignant Solid Neoplasm | Recruiting |
| NCT06022939 | Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone… | AL Amyloidosis | Recruiting |
| NCT06998940 | Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or… | Locally Advanced Pancreatic Adenocarcinoma | Recruiting |
| NCT05561387 | Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a… | Plasma Cell Myeloma | Recruiting |
| NCT07383441 | Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer | Advanced Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT01674140 | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | Breast Cancer | Active, Not Recruiting |
| NCT03091660 | S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle… | Stage 0 Bladder Urothelial Carcinoma | Active, Not Recruiting |
| NCT01349881 | S0820, Adenoma and Second Primary Prevention Trial | Colorectal Neoplasms | Active, Not Recruiting |
| NCT05633602 | Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent… | Recurrent Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| NCT03757949 | Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be… | Bladder Carcinoma | Active, Not Recruiting |
| NCT07578116 | Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That… | Anatomic Stage IV Breast Cancer AJCC v8 | Not Yet Recruiting |
| NCT07615049 | Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas… | Recurrent Soft Tissue Sarcoma of the Trunk and Extremities | Not Yet Recruiting |
| NCT02785952 | Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating… | Recurrent Squamous Cell Lung Carcinoma | Active, Not Recruiting |
| NCT04155034 | S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus… | Extensive Stage Lung Small Cell Carcinoma | Active, Not Recruiting |
| NCT07220187 | Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter… | Richter Syndrome | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06616584 | Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced… | Recurrent Lung Non-Small Cell Carcinoma | Recruiting |
| NCT03851445 | Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer | Previously Treated Non-Small Cell Lung Cancer | Recruiting |
| NCT05096663 | Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus… | Advanced Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT05806515 | Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an… | Prostate Adenocarcinoma | Recruiting |
| NCT05633615 | Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory… | Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT06769126 | Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage… | Extensive Stage Lung Small Cell Carcinoma | Recruiting |